Potentials of the Cuban biopharmaceutical industry
Unique medicines of its kind in the world such as Heberprot-P, the CIMAvax-EGF vaccine, as well as the creation of therapies for the treatment of diseases of the central nervous system, cancer, hepatitis B or meningoencephalitis have turned Cuba into a world power in biotechnology.
In this opportunity, we present the Cuban company BioCubaFarma responsible for developing joint projects in the field of biotechnology and the production of medicines against cancer and other diseases.